s-sulphocysteine has been researched along with levodopa in 1 studies
Studies (s-sulphocysteine) | Trials (s-sulphocysteine) | Recent Studies (post-2010) (s-sulphocysteine) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
---|---|---|---|---|---|
72 | 0 | 18 | 17,774 | 1,900 | 4,946 |
Protein | Taxonomy | s-sulphocysteine (IC50) | levodopa (IC50) |
---|---|---|---|
integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, GF; Clayton, PT; Footitt, EJ; Heales, SJ; Mills, PB; Oppenheim, M | 1 |
1 other study(ies) available for s-sulphocysteine and levodopa
Article | Year |
---|---|
Pyridoxal 5'-phosphate in cerebrospinal fluid; factors affecting concentration.
Topics: Adolescent; Adult; Biopterins; Child; Child, Preschool; Cysteine; Epilepsy; False Positive Reactions; Female; Free Radicals; Humans; Infant; Infant, Newborn; Levodopa; Male; Metabolism, Inborn Errors; Middle Aged; Nervous System Diseases; Oxygen; Pyridoxal Phosphate; Reference Values; Reproducibility of Results; Sulfites; Tetrahydrofolates | 2011 |